Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.62
-1.20 (-8.07%)
At close: Nov 12, 2026, 4:00 PM EST
13.63
+0.01 (0.07%)
Pre-market: Nov 13, 2026, 4:02 AM EST
Trevi Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $28 | Buy | Maintains | $28 | +105.58% | Nov 10, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $23 | Buy | Reiterates | $23 | +68.87% | Nov 10, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $25 | Buy | Reiterates | $25 | +83.55% | Nov 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +120.26% | Nov 10, 2026 |
| Needham | Needham | Buy Maintains $23 | Buy | Maintains | $23 | +68.87% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $24 | Buy | Reiterates | $24 | +76.21% | Nov 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $30 | Buy | Reiterates | $30 | +120.26% | Nov 10, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $36 | Buy | Maintains | $36 | +164.32% | Nov 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.